Hormonal
Intensive glycemic control fails to significantly improve cardiovascular outcomes in patients with diabetes, whereas cholesterol-lowering therapy significantly reduces cardiovascular events regardless of baseline lipid profiles.
If you have diabetes, managing your blood sugar is crucial for preventing kidney and eye damage, but it will not significantly protect your heart. To reduce your risk of heart attack or stroke, you must prioritize lowering your LDL cholesterol, even if your levels appear 'normal' on a standard test. Statin therapy is the most effective intervention for cardiovascular prevention in diabetes, regardless of your baseline lipid levels.
Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. ... there is strong evidence that cholesterol lowering improves cardiovascular outcomes, even in patients with apparently unremarkable lipid profiles.
Why this rating
Supported by multiple large-scale randomized controlled trials (DCCT, UKPDS, ACCORD, CARDS, HPS) and meta-analyses cited in the text.
Source
Diabetes Dyslipidemia
Jonathan Schofield et al. · Diabetes Therapy · 2016
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →